- Home
- / Evox Therapeutics
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Evox Therapeutics financials data including stock price, CreditSafe score, and balance sheet.
CreditSafe Score
?
Score changed on Jun 07, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| GBP | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|
| Cash | 8.9M | 5.3M | 36.3M |
| Accounts Receivable | 151.0K | 350.0K | |
| Current Assets | 9.1M | 6.5M | 38.0M |
| PP&E | 75.3K | 460.7K | 1.1M |
| Total Assets | 9.2M | 6.9M | 39.1M |
| Accounts Payable | 121.8K | 155.2K | 359.3K |
| Current Liabilities | 135.8K | 481.1K | 1.5M |
| Short-term Debt | 11.7K | ||
| Non-Current Liabilities | 16.0K | ||
| Total Debt | 11.7K | ||
| Total Liabilities | 135.8K | 481.1K | 1.5M |
| Common Stock | 3.2K | 3.2K | 6.3K |
| Retained Earnings | (1.0M) | (3.7M) | (8.6M) |
| Total Equity | 9.1M | 6.4M | 37.6M |
| Financial Leverage | 1 | 1.1 | 1 |